APH

Amphenol Corporation

$80.28

+1.17% 2026-10-19

Information TechnologyS&P 500

1M 3M 6M 1Y 2Y

APHSPY

-6.9%

+3.7%

+6.8%

+5.4%

YTD

+19.4%

+28.7%

Grades vs sector

Momentum

49th pct in sector

C+

12-1 return: +21.8%
Percentile within its GICS sector across the S&P 1500.

Growth

92nd pct in sector

Revenue growth (YoY): +55.0%
Percentile within its GICS sector across the S&P 1500.

Value

38th pct in sector

C-

Forward E/P: 4.2% · EBITDA/EV: 4.5%
Percentile within its GICS sector across the S&P 1500.

Profitability

77th pct in sector

B+

Profit margin: +17.7% · Return on equity: +38.1%
Percentile within its GICS sector across the S&P 1500.

Revisions

no data

–

EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Our models

Held by 1 of 3 live models: Quality Growth.

Quality Growth

6.7% of the book · rank 12 of 360

Held Momentum Top 15

rank 142 of 499 · 12-1 momentum % 28.8

Momentum Blend

not in the current book

Why it's in Quality Growth #12 of 360

Qualified on ROIC 58%, revenue +54% (TTM), growth accelerating +5.4 pts, latest quarter 2026-06-30. Ranked 12th of 360 at the 2026-09-30 rebalance.

What would knock it out: Drops out if it falls outside the top 15 at the next rebalance (Oct 30). In the latest preview (2026-10-16) it ranks 12th.

Key stats

Market cap$198.0B

P/E (trailing)40.1

P/E (forward)24.1

52-week range59.01 – 89.93

Revenue growth (YoY, latest qtr)+55.0%

Dividend yield0.63%

Analyst consensusStrong Buy (19)

Mean price target$102.97 (+28%)

Valuation & fundamentals

Bottom line

Looks undervalued

Model read-out from the numbers below, not advice. Score +3 (DCF counts double).

▲DCF (base case)above the price by 32%

▼Forward P/E vs sector24.1x vs median 16.9x

▲Piotroski F-score7/9

▲Altman Z5.9 (safe)

▲Net debt / EBITDA-0.2x

▲Analyst target+28% (19 analysts)

Discounted cash flow

Bear

$49

-39%

growth 18% · disc. 11.4% · term. 2.0%

Base

$106

+32%

growth 30% · disc. 10.4% · term. 2.5%

Bull

$192

+139%

growth 38% · disc. 9.4% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal

Today's price assumes free cash flow grows about 19% a year for 10 years.

Implied

+19%/yr

FCF, last 3 yrs

+35%/yr

FCF, last 5 yrs

+27%/yr

Revenue, last 3 yrs

+22%/yr

Revenue, last 5 yrs

+22%/yr

Same inputs as the DCF above: trailing free cash flow 4.7B, 10.4% discount rate, 2.5% growth after year 10, net cash and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.

Edit assumptions · recalculates instantly

Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.24 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs Information Technology

P/E (trailing)

sector median 35.9× · 56th pct

40.1×
pricier

Forward P/E

sector median 16.9× · 74th pct

24.1×
pricier

EV / EBITDA

sector median 20.8× · 51st pct

21.4×
pricier

Price / sales

sector median 4.6× · 65th pct

6.8×
pricier

Price / book

sector median 5.1× · 80th pct

12.8×
pricier

FCF yield

sector median 3.5% · 38th pct

2.4%
pricier

Forward EPS $3.33 vs trailing $2.00 (+67% expected growth). Forward P/E uses analysts' next-12-month estimate.

Quality & financial health

Gross margin

38.5%

Operating margin

27.0%

FCF margin

16.2%

Net margin

17.7%

Return on equity

33.2%

Return on invested capital

41.7%

Net debt / EBITDA

-0.2×

Current ratio

1.9×

Interest cover

12.4×

Cash conversion (OCF/NI)

1.1×

Piotroski F-score 7/9 · last two fiscal years

✓ Positive net income✓ Positive operating cash flow✓ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✓ Current ratio improved✗ No share dilution✓ Gross margin improved✗ Asset turnover improved

Altman Z-score 5.9 (safe zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.

Analysts

Mean target

$103

+28%

Analysts

Strong Buy

Range

$85–$116

low – high

● price · ◆ mean target

Annual history

FY	Revenue	Net income	Free cash flow
2025	$23.1B	$4.3B	$4.4B
2024	$15.2B	$2.4B	$2.1B
2023	$12.6B	$1.9B	$2.2B
2022	$12.6B	$1.9B	$1.8B
2021	$10.9B	$1.6B	$1.2B
2020	$8.6B	$1.2B	$1.3B

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +22.3%.

Earnings

Next report: 2026-10-28 · before open · EPS est 0.73

EstimateActual (beat)Actual (miss)

Report	EPS est	Actual	Surprise
2026-07-29	1.19	1.35	+13.2%
2026-04-29	0.95	1.06	+12.0%
2026-01-28	0.94	0.97	+3.1%
2025-10-22	0.80	0.93	+16.5%
2025-07-23	0.67	0.81	+21.7%
2025-04-23	0.52	0.63	+21.0%
2025-01-22	0.50	0.55	+9.2%
2024-10-23	0.45	0.50	+10.4%

Quarterly revenue

Quarter	Revenue	YoY
2026-03-31	$7.6B	+58.4%
2025-12-31	$6.4B	–
2025-09-30	$6.2B	–
2025-06-30	$5.7B	–
2025-03-31	$4.8B	–

Analyst actions

Evercore ISI Group

2026-10-12 · main

Outperform → Outperform
PT $100

Citigroup

2026-10-08 · main

Buy → Buy
PT $112

UBS

2026-10-07 · main

Buy → Buy
PT $105

Goldman Sachs

2026-10-06 · main

Buy → Buy
PT $116

Bernstein

2026-09-23 · init

→ Outperform
PT $99

BNP Paribas

2026-09-22 · main

Outperform → Outperform
PT $110

Recent dividends

2026-09-22: $0.125 · 2026-06-23: $0.125 · 2026-03-23: $0.125 · 2025-12-16: $0.125 · 2025-09-16: $0.083 · 2025-06-17: $0.083 · 2025-03-18: $0.083 · 2024-12-17: $0.083

Insider trades

Silverman David M

EVP, Human Resources · 2026-08-05

SELL
$20.9M

Lampo Craig A

EVP& CFO · 2026-08-04

SELL
$32.3M

D'Amico Lance E

EVP, Secretary & GenCounsel · 2026-08-03

SELL
$8.1M

D'Amico Lance E

EVP, Secretary & GenCounsel · 2026-08-03

SELL
$6.5M

D'Amico Lance E

EVP, Secretary & GenCounsel · 2026-08-03

SELL
$1.6M

Norwitt Richard Adam

Director, President & CEO · 2026-07-31

SELL
$80.8M

Norwitt Richard Adam

Director, President & CEO · 2026-07-31

SELL
$30.2M

None

None · None

SELL
–

News

What Capital Group Core Equity ETF (CGUS) Bought: Medline Leads on Thursday

GuruFocus.com · 17h ago

These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Eli Lilly Leads Industry

Investor's Business Daily · Oct 17

iShares MSCI USA Min Vol Factor ETF (USMV) Sells Microsoft and Amphenol on Oct. 13

GuruFocus.com · Oct 15

Stats refreshed 2026-10-19 17:47:13 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

coteau

Coteau Systematic StrategiesSystematic equity research and model portfolios.
Coteau Systematic Strategies publishes research, model portfolios and tools. It does not manage money or offer investment advice. Model results are hypothetical. Data: Yahoo Finance (delayed), SEC EDGAR.

What is Coteau?Disclaimer Terms Privacy Data status